Clinical Trial Update: Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase II study evaluating Abraxane plus gemcitabine in advanced adenocarcinoma non-small cell lung cancer progressing after first-line platinum therapy has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Patients With Stage IV or Recurrent Adenocarcinoma of the Lung | Phase 2 | Status: COMPLETED | Results posted: 2021-09-29